| Literature DB >> 35346390 |
Nessa Ryan1, Dorice Vieira2, Joyce Gyamfi3, Temitope Ojo4, Donna Shelley5, Olugbenga Ogedegbe6, Juliet Iwelunmor7, Emmanuel Peprah3,4.
Abstract
BACKGROUND: Several tools to improve reporting of implementation studies for evidence-based decision making have been created; however, no tool for critical appraisal of implementation outcomes exists. Researchers, practitioners, and policy makers lack tools to support the concurrent synthesis and critical assessment of outcomes for implementation research. Our objectives were to develop a comprehensive tool to (1) describe studies focused on implementation that use qualitative, quantitative, and/or mixed methodologies and (2) assess risk of bias of implementation outcomes.Entities:
Keywords: Critical appraisal; Implementation outcomes; Implementation strategies; Meta-analysis; Mixed methods; Qualitative methods; Quantitative methods; Reporting tool; Systematic review
Year: 2022 PMID: 35346390 PMCID: PMC8959802 DOI: 10.1186/s43058-021-00236-4
Source DB: PubMed Journal: Implement Sci Commun ISSN: 2662-2211
Fig. 1Phases of modified nominal group technique and e-consensus meeting. Adapted from McMillan SS, King M, Tully MP. How to use the nominal group and Delphi techniques. Int J Clin Pharm. 2016;38(3):655-662. doi:10.1007/s11096-016-0257-x and Moher D, Schulz KF, Simera I, Altman DG. Guidance for Developers of Health Research Reporting Guidelines. PLOS Medicine. 2010;7(2):e1000217
Summary of tools integrated into the ASSESS tool
| Tool | Function |
|---|---|
| TiDier checklist (Hoffman et al., 2014) | Reporting intervention studies |
| Stari checklist (Pinnock et al., 2017) | Reporting implementation studies |
| FRAME framework (Stirman et al., 2019) | Reporting adaptation to an intervention content and/or its delivery |
| MMAT tool (Hong et al., 2018) | Critical appraisal for mixed method studies |
| Taxonomy for implementation outcomes (Proctor et al., 2011) | Description of implementation outcomes |
ASSESS tool item descriptions
| # | Item | Description |
|---|---|---|
| 1 | Review or meta-analysis question | The overall question guiding the review or meta-analysis |
| Notes | Use this space to write notes to yourself or other extractors regarding decisions on how to enter data | |
| Reported on page # | When used as a reporting tool, indicate the page number where the indicated information can be found | |
| ARTICLE CITATION | ||
| 2 | Study author, publication year | Indicate the study author name and publication year |
| 3 | Study title | Indicate the study title |
| INTRODUCTION | ||
| Implementation strategy | “Implementation strategy” refers to how the intervention was implemented. | |
| Intervention strategy | “Intervention” refers to the healthcare or public health intervention that is being implemented. | |
| 4 | Rationale | For implementation strategy: the scientific background and rationale for the implementation strategy (including any underpinning theory/framework/model, how it is expected to achieve its effects and any pilot work). For intervention: the scientific background and rationale for the intervention being implemented (including evidence about its effectiveness and how it is expected to achieve its effects). |
| 5 | Aim(s), objective(s), or research question(s) | Are there clear aims, objectives, or research questions? Indicate the primary (upon which the study was primarily designed to address) and the secondary (addressing this is prioritized after the primary) |
| METHODS: DESCRIPTION | ||
| 6 | Descriptions | A description of the intervention and implementation strategy. Identify the components that are core components vs those that are tangential and modifiable for the context, if possible. |
| 7 | Adaptation | A description of any adaptation that has and/or will occur. |
| 8 | Design | The design and key features of the evaluation, (cross referencing to any appropriate methodology reporting standards) and any changes to study protocol, with reasons |
| 9 | Participant types | Who are the participants in the intervention and implementation strategy |
| 10 | Comparison group | If experimental design, indicate the comparison group for the intervention and/or implementation strategy |
| 11 | Context | The context in which the intervention was implemented. |
| 12 | Sites | The characteristics of the targeted ‘site(s)’ (e.g locations/personnel/resources etc.) for implementation and any eligibility criteria. |
| 13 | Subgroups (optional) | Any sub-groups recruited for additional research tasks, and/or nested studies are described |
| 14 | Implementation phase | Indicate whether evaluation occurred pre-, during , and/or post-implementation |
| 15 | Process evaluation | Process evaluation objectives and outcomes related to the mechanism by which the strategy is expected to work |
| 16 | Sample size | Rationale for sample sizes (including sample size calculations, budgetary constraints, practical considerations, data saturation, as appropriate) |
| 17 | Analysis | Methods of analysis (with reasons for that choice) |
| 18 | Sub-group analyses | Any a priori sub-group analyses (e.g. between different sites in a multicenter study, different clinical or demographic populations), and sub-groups recruited to specific nested research tasks |
| 19 | Outcomes (assessment) (Implementation) | Defined pre-specified primary and other outcome(s) of the implementation strategy, and how they were assessed. Document any pre-determined targets |
| Quantitative column | Input the specific outcome | |
| Qualitative column | Input the specific outcome | |
| Acceptability | the perception among implementation stakeholders (beneficiaries and implementers) that the innovation is agreeable, palatable, or satisfactory | |
| Adoption | the intention, initial decision, or action to try or employ the innovation (i.e. uptake) | |
| Appropriateness | the perceived fit, relevance, or compatibility of the innovation for a given practice setting, provider, or beneficiary; and/or perceived fit of the innovation to address a particular issue or problem (OH prevention). | |
| Feasibility | the extent to which the innovation can be successfully used or carried out within a given agency or setting | |
| Fidelity | degree to which the innovation can be implemented as it was prescribed in the original protocol or as it was intended by the program developer | |
| Cost | (incremental or implementation cost) is defined as the cost impact of an implementation effort | |
| Penetration | the integration of a practice within a service setting and its subsystems | |
| Sustainability | the extent to which a newly implemented innovation is maintained or institutionalized within a service setting’s ongoing, stable operations | |
| 19 | Outcomes (assessment) (Intervention) | Defined pre-specified primary and other outcome(s) of the intervention (if assessed), and how they were assessed. Document any pre-determined targets |
| Quantitative column | Input the specific outcome | |
| Qualitative column | Input the specific outcome | |
| Effectiveness | provision of services based on scientific knowledge to all who could benefit and refraining from providing services to those not likely to benefit (avoiding underuse and overuse, respectively) | |
| Efficiency | the avoidance of waste, including waste of equipment, supplies, ideas,and energy | |
| Equity | provision of care that does not vary in quality because of personalcharacteristics such as gender, ethnicity, geographic location, and socioeconomic status | |
| Patient centeredness | provision of care that is respectful of and responsive to individual patient preferences, needs, and values and ensuring that patient values guide all clinical decisions | |
| Safety | the avoidance of injuries to patients from the care that is intended to help them | |
| Timeliness | reduction of waits and sometimes harmful delays for both thosewho receive and those who give care | |
| RESULTS: DESCRIPTION | ||
| 20 | Outcomes (findings) (Implementation) | Defined pre-specified primary and other outcome(s) of the implementation strategy, and how they were assessed. Document any pre-determined targets |
| Quantitative column | Input the specific outcome | |
| Qualitative column | Input the specific outcome | |
| Acceptability | the perception among implementation stakeholders (beneficiaries and implementers) that the innovation is agreeable, palatable, or satisfactory | |
| Adoption | the intention, initial decision, or action to try or employ the innovation (i.e. uptake) | |
| Appropriateness | the perceived fit, relevance, or compatibility of the innovation for a given practice setting, provider, or beneficiary; and/or perceived fit of the innovation to address a particular issue or problem (OH prevention). | |
| Feasibility | the extent to which the innovation can be successfully used or carried out within a given agency or setting | |
| Fidelity | degree to which the innovation can be implemented as it was prescribed in the original protocol or as it was intended by the program developer | |
| Cost | (incremental or implementation cost) is defined as the cost impact of an implementation effort | |
| Penetration | the integration of a practice within a service setting and its subsystems | |
| Sustainability | the extent to which a newly implemented innovation is maintained or institutionalized within a service setting’s ongoing, stable operations | |
| 20 | Outcomes (findings) (Intervention) | Defined pre-specified primary and other outcome(s) of the intervention (if assessed), and how they were assessed. Document any pre-determined targets |
| Quantitative column | Input the specific outcome | |
| Qualitative column | Input the specific outcome | |
| Effectiveness | provision of services based on scientific knowledge to all who could benefit and refraining from providing services to those not likely to benefit (avoiding underuse and overuse, respectively) | |
| Efficiency | the avoidance of waste, including waste of equipment, supplies, ideas,and energy | |
| Equity | provision of care that does not vary in quality because of personalcharacteristics such as gender, ethnicity, geographic location, and socioeconomic status | |
| Patient centeredness | provision of care that is respectful of and responsive to individual patient preferences, needs, and values and ensuring that patient values guide all clinical decisions | |
| Safety | the avoidance of injuries to patients from the care that is intended to help them | |
| Timeliness | reduction of waits and sometimes harmful delays for both thosewho receive and those who give care | |
| 21 | Barriers to implementation | Identify any factors examined that do or could challenge successful implementation |
| 22 | Facilitators of implementation | Identify any factors examined that do or could support successful implementation |
| METHODS: EVALUATION | ||
| 23 | Design | Follow steps 1, 2, and 3 |
| Step 1 | Insert design type: Qualitative, Quantitative RCT, Quantitative non-randomized, or Mixed methods | |
| Step 2 | Step 2 insert 5 corresponding criteria from instructions | |
| Qualitative criteria | 1.1. Is the qualitative approach appropriate to answer the research question? | |
| 1.2. Are the qualitative data collection methods adequate to address the research question? | ||
| 1.3. Are the findings adequately derived from the data? | ||
| 1.4. Is the interpretation of results sufficiently substantiated by data? | ||
| 1.5. Is there coherence between qualitative data sources, collection, analysis and interpretation? | ||
| Quantitative, RCT criteria | 2.1. Is randomization appropriately performed? | |
| 2.2. Are the groups comparable at baseline? | ||
| 2.3. Are there complete outcome data? | ||
| 2.4. Are outcome assessors blinded to the intervention provided? | ||
| 2.5 Did the participants adhere to the assigned intervention? | ||
| Quantitative, non-randomized criteria | 3.1. Are the participants representative of the target population? | |
| 3.2. Are measurements appropriate regarding both the outcome and intervention (or exposure)? | ||
| 3.3. Are there complete outcome data? | ||
| 3.4. Are the confounders accounted for in the design and analysis? | ||
| 3.5. During the study period, is the intervention administered (or exposure occurred) as intended? | ||
| Mixed methods criteria | 4.1. Is there an adequate rationale for using a mixed methods design to address the research question? | |
| 4.2. Are the different components of the study effectively integrated to answer the research question? | ||
| 4.3. Are the outputs of the integration of qualitative and quantitative components adequately interpreted? | ||
| 4.4. Are divergences and inconsistencies between quantitative and qualitative results adequately addressed? | ||
| 4.5. Do the different components of the study adhere to the quality criteria of each tradition of the methods involved? | ||
| Step 3 | Provide score (0 or 1) to each criteria where 1 indicates that the criteria was met and 0 indicates the criteria was not met | |
| RESULTS: EVALUATION | ||
| Step 4 | Sum the score from Step 3 and apply to the outcomes assessed | |
| 24 | Outcomes | |
| Bias Column | Indicate the degree of bias based on the design and methods, where 1-2=higher bias and 3-5=lower bias. Can also input 'unclear' if the degree of bias cannot be determined, or 'NA' for outcomes not assessed | |
Sample characteristics of consensus meeting participants regarding usability testing (N = 32)
| Characteristic | |
|---|---|
| Gender | 27 (84%) female |
| Education | 11 (34%) bachelors |
| 11 (34%) masters | |
| 10 (31%) MD or PhD | |
| Disciplines | 18 (56%) students |
| 10 (31%) researchers | |
| 2 (6%) physicians | |
| 1 (3%) nurse | |
| 1 (3%) postdoc | |
| 1 (3%) professor | |
| 1 (3%) hospital administrator | |
| 1 (3%) nutritionist | |
| 1 (3%) allied health professional | |
| 1 (3%) clinical manager | |
| Implementation science experience | 3 (9%) formal implementation science training |
| 7 (32%) among researchers, those who use Implementation Science frameworks/theories | |
| 5 (63%) among those engaged in Implementation Science research with 1 year or less of experience |
Participant feedback on utility and usability (N = 9)
| Statement | % agree/strongly agree |
|---|---|
| This tool is | 100% |
| This tool | 100% |
| This tool could | 89% |
| The use of this tool could | 100% |
| I am | 78% |
| As this tool | 33% |